Apellis Pharmaceuticals, Inc. i-capital capital
Apellis Pharmaceuticals, Inc. capitalization kwi-intanethi namhlanje kwiidola. Ulwazi lwe Apellis Pharmaceuticals, Inc. capitalisation ithathwe kwimithombo evulekileyo. Apellis Pharmaceuticals, Inc. capitalisation ibalwa ngokusekelwe kuthengiso lwesitokhwe. Apellis Pharmaceuticals, Inc. ikhonkco yentengiso namhlanje yi- $ 9 685 843 968.
Apellis Pharmaceuticals, Inc. ivolumu yezorhwebo
Apellis Pharmaceuticals, Inc. umthamo wokurhweba namhlanje = 196 001 iidola zaseMelika. Itshathi yemihla ngemihla yokurhweba ye Apellis Pharmaceuticals, Inc. ikwiwebhusayithi yethu. Apellis Pharmaceuticals, Inc. ukurhweba kwi-intanethi okuthengiswa kwiimarike ezininzi zesitokhwe, sibonisa umthamo opheleleyo Apellis Pharmaceuticals, Inc. ngosuku. Apellis Pharmaceuticals, Inc. i-capitalization ikhula nge- $ 26 722 304.
|
Apellis Pharmaceuticals, Inc. istatshi yekhredithi yemakethe
Apellis Pharmaceuticals, Inc. capitalisation kwigrafu ngeminyaka. Ngaphezulu kwenyanga, Apellis Pharmaceuticals, Inc. capitalisation itshintshwe ngu 0%. Apellis Pharmaceuticals, Inc. utshintsho lwemali enkulu enyakeni 0%. Iimali yentengiso enkulu ye Apellis Pharmaceuticals, Inc. ngoku ilingana nayo 9 685 843 968 iidola zaseMelika.
Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Apellis Pharmaceuticals, Inc. imbali yenkxaso-mali
Umhla |
Ixabiso
Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
|
---|---|
03/05/2023 | 9 685 843 968 $ |
02/05/2023 | 9 659 121 664 $ |
01/05/2023 | 9 617 297 408 $ |
28/04/2023 | 9 589 995 520 $ |
27/04/2023 | 9 656 217 600 $ |
26/04/2023 | 10 138 679 296 $ |
25/04/2023 | 10 454 354 944 $ |
Apellis Pharmaceuticals, Inc. isatifiketi somqulu
Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Apellis Pharmaceuticals, Inc. idatha yembali yevolumu
Umhla |
Umqulu (24h)
Ixabiso lezorhwebo leApellis Pharmaceuticals, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-APLS ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
|
---|---|
03/05/2023 | 196 001 $ |
02/05/2023 | 1 212 570 $ |
01/05/2023 | 1 460 879 $ |
28/04/2023 | 151 223 $ |
27/04/2023 | 1 985 743 $ |
26/04/2023 | 934 832 $ |
25/04/2023 | 1 350 399 $ |
Apellis Pharmaceuticals, Inc. capitalization e 03/05/2023 ifikelele kuthi 9 685 843 968 iidola zaseMelika. Apellis Pharmaceuticals, Inc. i-capitalisation yentengiso kwi 02/05/2023 ilingana ne 9 659 121 664 iidola zaseMelika. Apellis Pharmaceuticals, Inc. capitalisation yimali eyi- $ 9 617 297 408 kwi 01/05/2023. Iimali yentengiso enkulu ye Apellis Pharmaceuticals, Inc. ifikelele kwi 9 589 995 520 Iidola zaseMelika ku- 28/04/2023.
27/04/2023 Apellis Pharmaceuticals, Inc. capitalization ilingane 9 656 217 600 iidola zaseMelika. 26/04/2023 Apellis Pharmaceuticals, Inc. capitalised eyi- 10 138 679 296 iidola zaseMelika. Apellis Pharmaceuticals, Inc. capitalization ilingane 10 454 354 944 Iidola zaseMelika ku- 25/04/2023.
Inkcitho ye-Apellis Pharmaceuticals, Inc. namhlanje ngu-9 685 843 968 $. Iimali zentengiso ye-Apellis Pharmaceuticals, Inc. ishintshile +0.28% xa kuthelekiswa nezolo. Imali yokuthengisa ye APLS izabelo ze Apellis Pharmaceuticals, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-196 001 $. Ixabiso lokuthengiswa kwezabelo ze Apellis Pharmaceuticals, Inc. latshintshile kwi--83.836% xa kuthelekiswa nosuku lwangaphambili lworhwebo.